AVIATION Study: A Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy Study of TERN-201 in Patients With Non-Cirrhotic Non-Alcoholic Steatohepatitis
Public ClinicalTrials.gov record NCT04897594. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-Center, Randomized, Double-Blind, Dose-Ranging, Placebo-Controlled, Proof of Concept, Adaptive, Phase 1b Clinical Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of Orally Administered TERN-201 in Patients With Presumed Non-Cirrhotic Non-Alcoholic Steatohepatitis (NASH)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a Phase 1b multi-center, randomized, double-blind, dose-ranging, placebo-controlled, adaptive study to evaluate the safety, pharmacokinetics (PK), pharmacodynamics (PD) of TERN-201 in patients with non-cirrhotic NASH.
Study identification
- NCT ID
- NCT04897594
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- 52 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 20, 2021 (Actual)
- Primary completion
- Sep 2, 2022 (Actual)
- Completion
- Sep 2, 2022 (Actual)
- Last update posted
- Jun 7, 2024
2021 – 2022
United States locations
- U.S. sites
- 11
- U.S. states
- 4
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Terns Clinical Study Site 1018 | Tucson | Arizona | 85712 | — |
| Terns Clinical Study Site 1024 | Tucson | Arizona | 85712 | — |
| Terns Clinical Study Site 1004 | Coronado | California | 92117 | — |
| Terns Clinical Study Site 1039 | Los Angeles | California | 90048 | — |
| Terns Clinical Study Site 1001 | Panorama City | California | 91402 | — |
| Terns Clinical Study Site 1040 | Rialto | California | 92377 | — |
| Terns Clinical Study Site 1013 | San Diego | California | 92093 | — |
| Terns Clinical Study Site 1010 | Bastrop | Louisiana | 71220 | — |
| Terns Clinical Study Site 1006 | San Antonio | Texas | 78215 | — |
| Terns Clinical Study Site 1003 | San Antonio | Texas | 78229 | — |
| Terns Clinical Study Site 1019 | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04897594, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 7, 2024 · Synced Oct 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04897594 live on ClinicalTrials.gov.